Severance and stock options drive Korea pharma executive pay surge
Summary
Severance and stock options drive Korea pharma executive pay surge Payouts swell on one-off exits and equity windfalls as owner clans sit near 1–2 bil
Description
Severance and stock options drive Korea pharma executive pay surge Payouts swell on one-off exits and equity windfalls as owner clans sit near 1–2 bil
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source